130 related articles for article (PubMed ID: 9211542)
1. Reversible occlusion shunt for intraventricular chemotherapy in shunt-dependent brain tumor patients.
Czech T; Reinprecht A; Dietrich W; Hainfellner JA; Slavc I
Pediatr Hematol Oncol; 1997; 14(4):375-80. PubMed ID: 9211542
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.
Slavc I; Schuller E; Czech T; Hainfellner JA; Seidl R; Dieckmann K
J Neurooncol; 1998; 38(2-3):213-8. PubMed ID: 9696374
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration.
Clayton J; Vloeberghs M; Jaspan T; Walker D; MacArthur D; Grundy R
Acta Neurochir (Wien); 2008 Jul; 150(7):709-12. PubMed ID: 18401539
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting the need for cerebrospinal fluid diversion following posterior fossa tumor surgery in children.
Gopalakrishnan CV; Dhakoji A; Menon G; Nair S
Pediatr Neurosurg; 2012; 48(2):93-101. PubMed ID: 23038047
[TBL] [Abstract][Full Text] [Related]
5. Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.
Stewart CF; Iacono LC; Chintagumpala M; Kellie SJ; Ashley D; Zamboni WC; Kirstein MN; Fouladi M; Seele LG; Wallace D; Houghton PJ; Gajjar A
J Clin Oncol; 2004 Aug; 22(16):3357-65. PubMed ID: 15310781
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
Terterov S; Krieger MD; Bowen I; McComb JG
J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.
Fouladi M; Gajjar A; Boyett JM; Walter AW; Thompson SJ; Merchant TE; Jenkins JJ; Langston JW; Liu A; Kun LE; Heideman RL
J Clin Oncol; 1999 Oct; 17(10):3234-7. PubMed ID: 10506624
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis.
Kim HS; Park JB; Gwak HS; Kwon JW; Shin SH; Yoo H
World J Surg Oncol; 2019 Mar; 17(1):59. PubMed ID: 30917830
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery.
Schneider C; Ramaswamy V; Kulkarni AV; Rutka JT; Remke M; Tabori U; Hawkins C; Bouffet E; Taylor MD
J Neurosurg Pediatr; 2015 Mar; 15(3):236-42. PubMed ID: 25525930
[TBL] [Abstract][Full Text] [Related]
10. The risks of metastases from shunting in children with primary central nervous system tumors.
Berger MS; Baumeister B; Geyer JR; Milstein J; Kanev PM; LeRoux PD
J Neurosurg; 1991 Jun; 74(6):872-7. PubMed ID: 2033446
[TBL] [Abstract][Full Text] [Related]
11. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Tran HC; Gardner S; Weiner HL; Liebes LF; Finlay JL
J Oncol Pharm Pract; 2014 Jun; 20(3):229-32. PubMed ID: 23929729
[TBL] [Abstract][Full Text] [Related]
12. Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study.
Mosijczuk AD; Nigro MA; Thomas PR; Burger PC; Krischer JP; Morantz RA; Kurdunowicz B; Mulne AF; Towbin RB; Freeman AI
Cancer; 1993 Nov; 72(9):2755-62. PubMed ID: 8402500
[TBL] [Abstract][Full Text] [Related]
13. Ventriculolumber perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)-methyl]-1-(2-chloroethyl-1-nitrosou rea hydrochloride for subarachnoid dissemination of gliomas.
Ushio Y; Kochi M; Kitamura I; Kuratsu J
J Neurooncol; 1998; 38(2-3):207-12. PubMed ID: 9696373
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of preoperative ventricular volume on the need for permanent hydrocephalus treatment immediately after resection of posterior fossa medulloblastomas in children.
Kombogiorgas D; Natarajan K; Sgouros S
J Neurosurg Pediatr; 2008 Jun; 1(6):451-5. PubMed ID: 18518695
[TBL] [Abstract][Full Text] [Related]
15. Palliative ventriculoperitoneal shunt in a pediatric patient with recurrent metastatic medulloblastoma.
Schiff D; Kline C; Meltzer H; Auger J
J Palliat Med; 2009 Apr; 12(4):391-3. PubMed ID: 19327082
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma metastatic to the suprasellar region at diagnosis: a report of six cases with clinicopathologic correlation.
Helton KJ; Gajjar A; Hill DA; Boop FA; Kun LE; Langston JW
Pediatr Neurosurg; 2002 Sep; 37(3):111-7. PubMed ID: 12187055
[TBL] [Abstract][Full Text] [Related]
17. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
[TBL] [Abstract][Full Text] [Related]
18. Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
Gupta A; Kumar A; Abrari A; Patir R; Vaishya S
World Neurosurg; 2016 Sep; 93():485.e1-5. PubMed ID: 27450977
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors.
Gajjar A; Fouladi M; Walter AW; Thompson SJ; Reardon DA; Merchant TE; Jenkins JJ; Liu A; Boyett JM; Kun LE; Heideman RL
J Clin Oncol; 1999 Jun; 17(6):1825-8. PubMed ID: 10561221
[TBL] [Abstract][Full Text] [Related]
20. [Brain tumors in infants and children--factors affecting prognosis, (Part-3). Mode of metastasis and prognosis in medulloblastoma].
Oi S; Matsumoto S; Raimondi AJ
No Shinkei Geka; 1985 Dec; 13(12):1273-80. PubMed ID: 4088449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
